Interim results of clinician-rated symptom endpoints of a long-term, open-label study of levodopa-carbidopa intestinal gel in Parkinson's disease patients with severe motor fluctuations

被引：0
|
作者：
Fernandez, H. H.
Espay, A. J.
Standaert, D. G.
Benesh, J.
Lenz, R. A.
Caras, S. D.
Pritchett, Y. L.
Chatamra, K.
机构：
来源：
MOVEMENT DISORDERS | 2011年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
376
引用
收藏
页码：S126 / S126
页数：1
相关论文
共 50 条
  • [41] Long-term levodopa/carbidopa intestinal gel in advanced Parkinson’s disease
    María T. Cáceres-Redondo
    Fátima Carrillo
    María J. Lama
    Ismael Huertas-Fernández
    Laura Vargas-González
    Manuel Carballo
    Pablo Mir
    Journal of Neurology, 2014, 261 : 561 - 569
  • [42] Long-term safety and efficacy of 24-hour levodopa-carbidopa intestinal gel in Parkinson's disease
    Morales-Briceno, Hugo
    Mahant, Neil
    Ha, Ainhi D.
    Chang, Florence C. F.
    Kim, Samuel D.
    Griffith, Jane
    Tsui, David
    Galea, Donna
    Fung, Victor S. C.
    MOVEMENT DISORDERS, 2019, 34 (11) : 1747 - 1748
  • [43] Long-Term Safety by Levodopa Dose in Phase 3 Trials of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease
    Boyd, James T.
    Rodriguez, Ramon L.
    Hall, Coleen
    Eaton, Susan
    Dubow, Jordan
    Benesh, Janet
    ANNALS OF NEUROLOGY, 2014, 76 : S39 - S39
  • [44] Effect of levodopa-carbidopa intestinal gel on dyskinesia: Design of an open-label, randomized multicenter 12-week study in advanced Parkinson's disease patients
    Antonini, A.
    Poewe, W.
    Standaert, D.
    Zadikoff, C.
    Dubow, S.
    Bergmann, L.
    Hall, C.
    Robieson, W.
    Felipe, V.
    Barbato, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 180 - 180
  • [45] Effect of levodopa-carbidopa intestinal gel on dyskinesia: design of an open-label, randomized multicenter 12-week study in advanced Parkinson's disease patients
    Antonini, Angelo
    Poewe, Werner
    Standaert, David
    Zadikoff, Cindy
    Dubow, Stephanie
    Bergmann, Lars
    Yegin, Ashley
    Hall, Coleen
    Felipe, Vanessa
    Robieson, Weining
    Barbato, Luigi
    NEUROLOGY, 2017, 88
  • [46] Long-term safety from phase 3 trials of levodopa-carbidopa intestinal gel in patients with advanced Parkinson's disease
    Rodriguez, R. L.
    Schmulewitz, N.
    Hall, C.
    Eaton, S.
    Dubow, J.
    Benesh, J.
    MOVEMENT DISORDERS, 2014, 29 : S263 - S263
  • [47] Long-term effectiveness of levodopa-carbidopa intestinal gel on motor and non-motor symptoms in advanced Parkinson’s disease: results of the Italian GLORIA patient population
    Angelo Antonini
    Pietro Marano
    Graziano Gusmaroli
    Nicola Modugno
    Claudio Pacchetti
    Mariachiara Sensi
    Gabriella Melzi
    Lars Bergmann
    Maurizio Zibetti
    Leonardo Lopiano
    Neurological Sciences, 2020, 41 : 2929 - 2937
  • [48] Levodopa-carbidopa intestinal gel in routine care of advanced Parkinson's disease patients: Final long-term efficacy results on motor complications from the GLORIA registry
    Poewe, W.
    Kimber, T.
    Bermans, B.
    Odin, P.
    Antonini, A.
    Bajenaru, O.
    Onuk, K.
    Yegin, A.
    Bergmann, L.
    Chaudhuri, K. R.
    MOVEMENT DISORDERS, 2016, 31 : S651 - S652
  • [49] Effect of levodopa-carbidopa intestinal gel on dyskinesia: Design of an open-label, randomized multicenter 12-week study in advanced Parkinson's disease patients
    Antonini, A.
    Poewe, W.
    Standaert, D.
    Zadikoff, C.
    Dubow, S.
    Bergmann, L.
    Yegin, A.
    Hall, C.
    Robieson, W.
    Felipe, V.
    Barbato, L.
    MOVEMENT DISORDERS, 2017, 32
  • [50] Long-term effectiveness of levodopa-carbidopa intestinal gel on motor and non-motor symptoms in advanced Parkinson's disease: results of the Italian GLORIA patient population
    Antonini, Angelo
    Marano, Pietro
    Gusmaroli, Graziano
    Modugno, Nicola
    Pacchetti, Claudio
    Sensi, Mariachiara
    Melzi, Gabriella
    Bergmann, Lars
    Zibetti, Maurizio
    Lopiano, Leonardo
    NEUROLOGICAL SCIENCES, 2020, 41 (10) : 2929 - 2937
12345